Opus Genetics, Inc. (IRD)
4.135
+0.04
(+1.10%)
USD |
NASDAQ |
May 27, 16:00
4.135
0.00 (0.00%)
After-Hours: 18:40
Opus Genetics Free Cash Flow : -38.99M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Keros Therapeutics, Inc. | -58.25M |
| Xilio Therapeutics, Inc. | -57.36M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Amgen, Inc. | 8.597B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.73M |
| Cash from Financing (Quarterly) | 27.60M |
| Free Cash Flow Per Share (Quarterly) | -0.1465 |
| Free Cash Flow to Equity (Quarterly) | -37.53M |
| Free Cash Flow to Firm (Quarterly) | -12.08M |
| Free Cash Flow Yield | -12.97% |